Early relapse for Multiple Myeloma patients undergoing single auto-SCT: A single center experience

The purpose of this study was to understand the impact of early relapse (ER) on overall survival of myeloma patients. We analyzed the outcomes of 257 patients who received novel agent based inductions and underwent single auto-SCT at our center between 2010 and 2016. We conclude that ER, high-risk cytogenetics, and LDH>350 UI/L are significant prognosticators for poor patient outcome in multiple myeloma.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original Study Source Type: research